Immune Mediated Disease Therapeutics Developer Attovia Therapeutics Debuts on Nasdaq
SHANGHAI, Aug. 6, 2026 /PRNewswire/ -- Attovia Therapeutics, a portfolio company of Qiming Venture Partners and clinical-stage biopharmaceutical leader, successfully listed on the Nasdaq on August 5, 2026 Beijing time. Attovia Therapeutics (Nasdaq:...
V CAPITAL CONSULTING GROUP GUIDES SAGTEC GLOBAL LIMITED TO NASDAQ IPO, ACHIEVING FIFTH SUCCESSFUL LISTING
Consultancy Firm Secures Fifth Consecutive Success, Assisting Local Software Provider in Raising US$7 Million through Nasdaq IPO KUALA LUMPUR, Malaysia, March 14, 2025 /PRNewswire/ -- V Capital Consulting Group Limited ("VCCG", or the "Company") is...
Spirit Advisors Client PicoCELA Inc completes its Nasdaq IPO
TOKYO and NEW YORK, Jan. 20, 2025 /PRNewswire/ -- Spirit Advisors LLC proudly announces the successful completion of the initial public offering (IPO) of PicoCELA Inc. (Nasdaq: PCLA), a pioneer in wireless communication technology. As the first...